TY - JOUR
T1 - Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages
AU - Perronne, C.
AU - Gikas, A.
AU - Truffot-Pernot, C.
AU - Grosset, J.
AU - Pocidalo, J. J.
AU - Vilde, J. L.
PY - 1990
Y1 - 1990
N2 - The activities of clarithromycin, sulfisoxazole, and rifabutin against three virulent strains of Mycobacterium avium complex isolated from patients with acquired immunodeficiency syndrome were evaluated in a model of intracellular infection. Human monocyte-derived macrophages were infected at day 6 of culture with M. avium complex. Intracellular bacteria were counted 60 min after inoculation. Extra- and intracellular bacteria were counted at days 4 and 7 after inoculation. The concentrations used were 4 μg of clarithromycin per ml (KICs for the three strains, 4, 4, and 4 μg/ml), 50 μg of sulfisoxazole per ml (MICs, 50, 25, and 25 μg/ml), and 0.5 μg of rifabutin per ml (MICs, 2, 0.5, and 0.5 μg/ml). compared with controls, clarithromycin and rifabutin slowed the intracellular replication of the three strains (at day 7 after inoculation, P was <0.01 for the first strain and <0.001 for the two others). Sulfisoxazole was ineffective against the three strains. Clarithromycin was as effective as rifabutin. Clarithromycin plus rifabutin was as effective as each single agent. Clarithromycin plus sulfisoxazole was as effective as clarithromycin alone.
AB - The activities of clarithromycin, sulfisoxazole, and rifabutin against three virulent strains of Mycobacterium avium complex isolated from patients with acquired immunodeficiency syndrome were evaluated in a model of intracellular infection. Human monocyte-derived macrophages were infected at day 6 of culture with M. avium complex. Intracellular bacteria were counted 60 min after inoculation. Extra- and intracellular bacteria were counted at days 4 and 7 after inoculation. The concentrations used were 4 μg of clarithromycin per ml (KICs for the three strains, 4, 4, and 4 μg/ml), 50 μg of sulfisoxazole per ml (MICs, 50, 25, and 25 μg/ml), and 0.5 μg of rifabutin per ml (MICs, 2, 0.5, and 0.5 μg/ml). compared with controls, clarithromycin and rifabutin slowed the intracellular replication of the three strains (at day 7 after inoculation, P was <0.01 for the first strain and <0.001 for the two others). Sulfisoxazole was ineffective against the three strains. Clarithromycin was as effective as rifabutin. Clarithromycin plus rifabutin was as effective as each single agent. Clarithromycin plus sulfisoxazole was as effective as clarithromycin alone.
UR - http://www.scopus.com/inward/record.url?scp=0025030312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025030312&partnerID=8YFLogxK
U2 - 10.1128/AAC.34.8.1508
DO - 10.1128/AAC.34.8.1508
M3 - Article
C2 - 2171421
AN - SCOPUS:0025030312
SN - 0066-4804
VL - 34
SP - 1508
EP - 1511
JO - Antimicrobial agents and chemotherapy
JF - Antimicrobial agents and chemotherapy
IS - 8
ER -